UK markets closed

VYNE Therapeutics Inc. (VYNE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.6200+0.1200 (+4.80%)
At close: 04:00PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
30,620
30,908
42,250
57,563
Other short-term investments
62,633
0
0
1,027
Total cash
93,253
30,908
42,250
58,590
Net receivables
-
173
7,583
15,819
Inventory
-
-
7,291
7,404
Other current assets
2,656
2,300
4,903
4,591
Total current assets
95,963
38,275
63,186
87,259
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
207
0
905
2,581
Accumulated depreciation
-
0
-551
-443
Net property, plant and equipment
207
0
354
2,138
Other long-term assets
1,515
2,483
3,506
4,345
Total non-current assets
1,722
2,483
3,860
6,483
Total assets
97,685
40,758
67,046
93,742
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
1,659
2,386
6,510
4,780
Accrued liabilities
4,119
4,381
8,593
11,452
Other current liabilities
-
-
-
104
Total current liabilities
7,538
9,345
18,410
21,765
Non-current liabilities
Long-term debt
-
-
-
33,174
Other long-term liabilities
1,313
-
-
457
Total non-current liabilities
1,412
211
0
34,484
Total liabilities
8,950
9,556
18,410
56,249
Stockholders' equity
Common stock
1
0
5
4
Retained earnings
-691,336
-662,735
-639,525
-566,196
Accumulated other comprehensive income
26
0
0
0
Total stockholders' equity
88,735
31,202
48,636
37,493
Total liabilities and stockholders' equity
97,685
40,758
67,046
93,742